0

524752

DECIPHER

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

DECIPHER LABS LIMITED Share Price Today

Investment Returns

Over 1 Month -12.62% Over 3 Months 10.26% Over 6 Months -35.10% Over 1 Year -43.72%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

DECIPHER LABS LIMITED fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 6.30
  • P/E Ratio (TTM) -25.96
  • Beta 1.10
  • Book Value / share 8.15
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -0.17
info icon alternate text

DECIPHER LABS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 0.07
Operating Expense 0.24
Net Profit -0.17
Net Profit Margin (%) -242.85
Earnings Per Share (EPS) -0.17
EBITDA -0.17
Effective Tax Rate (%) 0.00
Particulars DEC 2025 (Values in Cr)
Revenue 0.13
Operating Expense 0.14
Net Profit -0.01
Net Profit Margin (%) -7.69
Earnings Per Share (EPS) -0.01
EBITDA -0.01
Effective Tax Rate (%) -100.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.09
Operating Expense 0.20
Net Profit -0.12
Net Profit Margin (%) -133.33
Earnings Per Share (EPS) -0.11
EBITDA -0.12
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.85
Operating Expense 0.79
Net Profit 0.06
Net Profit Margin (%) 7.05
Earnings Per Share (EPS) 0.06
EBITDA 0.06
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.23
Operating Expense 0.39
Net Profit -0.17
Net Profit Margin (%) -73.91
Earnings Per Share (EPS) -0.17
EBITDA -0.16
Effective Tax Rate (%) 0.00
Particulars MAR 2026 (Values in Cr)
Revenue 1.14
Operating Expense 1.38
Net Profit -0.25
Net Profit Margin (%) -21.92
Earnings Per Share (EPS) -0.24
EBITDA -0.22
Effective Tax Rate (%) -4.16
Particulars MAR 2025 (Values in Cr)
Revenue 0.85
Operating Expense 1.32
Net Profit -0.44
Net Profit Margin (%) -51.76
Earnings Per Share (EPS) -0.44
EBITDA -0.42
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 3.53
Operating Expense 3.53
Net Profit 0.02
Net Profit Margin (%) 0.56
Earnings Per Share (EPS) 0.02
EBITDA 0.04
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.81
Operating Expense 1.24
Net Profit -2.62
Net Profit Margin (%) -323.45
Earnings Per Share (EPS) -2.59
EBITDA -2.58
Effective Tax Rate (%) 0.75
Particulars MAR 2022 (Values in Cr)
Revenue 0.99
Operating Expense 0.68
Net Profit 0.36
Net Profit Margin (%) 36.36
Earnings Per Share (EPS) 0.36
EBITDA 0.41
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 22.63
ROE % 1.16
ROCE % -4.66
Total Debt to Total Equity 0.01
EBITDA Margin -2.51
Particulars MAR 2024 (Values in Cr)
Book Value / Share 21.64
ROE % -6.75
ROCE % -3.11
Total Debt to Total Equity 0.02
EBITDA Margin -0.71
Particulars MAR 2023 (Values in Cr)
Book Value / Share 22.98
ROE % 15.91
ROCE % 9.46
Total Debt to Total Equity 0.24
EBITDA Margin 7.03
Particulars MAR 2022 (Values in Cr)
Book Value / Share 23.93
ROE % 55.79
ROCE % 38.01
Total Debt to Total Equity 0.71
EBITDA Margin 20.97
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.55
ROE % 8.35
ROCE % 10.82
Total Debt to Total Equity 1.05
EBITDA Margin 7.43
Particulars MAR 2025 (Values in Cr)
Book Value / Share 8.40
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin -49.41
Particulars MAR 2024 (Values in Cr)
Book Value / Share 8.84
ROE % 0.16
ROCE % 0.16
Total Debt to Total Equity 0.00
EBITDA Margin 1.13
Particulars MAR 2023 (Values in Cr)
Book Value / Share 8.82
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -33.33
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.41
ROE % 2.20
ROCE % 2.19
Total Debt to Total Equity 0.01
EBITDA Margin 41.41
Particulars MAR 2021 (Values in Cr)
Book Value / Share 11.05
ROE % 0.61
ROCE % 0.72
Total Debt to Total Equity 0.02
EBITDA Margin 16.33
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.80
Total Assets 25.76
Total Liabilities 25.76
Total Equity 22.85
Share Outstanding 1
Price to Book Ratio 1.25
Return on Assets (%) -19.71
Return on Capital (%) -21.99
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 9.31
Total Assets 33.63
Total Liabilities 33.63
Total Equity 21.86
Share Outstanding 1
Price to Book Ratio 1.67
Return on Assets (%) -4.98
Return on Capital (%) -7.66
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.41
Total Assets 28.16
Total Liabilities 28.16
Total Equity 23.20
Share Outstanding 1
Price to Book Ratio 1.61
Return on Assets (%) -9.52
Return on Capital (%) -11.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 15.40
Total Assets 41.94
Total Liabilities 41.94
Total Equity 24.16
Share Outstanding 1
Price to Book Ratio 4.64
Return on Assets (%) 27.13
Return on Capital (%) 33.01
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.97
Total Assets 38.72
Total Liabilities 38.72
Total Equity 13.68
Share Outstanding 1
Price to Book Ratio 3.03
Return on Assets (%) 3.62
Return on Capital (%) 6.25
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 9.17
Total Liabilities 9.17
Total Equity 8.48
Share Outstanding 1
Price to Book Ratio 1.25
Return on Assets (%) -4.79
Return on Capital (%) -5.04
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 12.76
Total Liabilities 12.76
Total Equity 8.92
Share Outstanding 1
Price to Book Ratio 1.67
Return on Assets (%) 0.18
Return on Capital (%) 0.26
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 8.98
Total Liabilities 8.98
Total Equity 8.90
Share Outstanding 1
Price to Book Ratio 1.61
Return on Assets (%) -29.11
Return on Capital (%) -29.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 11.60
Total Liabilities 11.60
Total Equity 11.52
Share Outstanding 1
Price to Book Ratio 4.64
Return on Assets (%) 3.10
Return on Capital (%) 3.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 11.39
Total Liabilities 11.39
Total Equity 11.16
Share Outstanding 1
Price to Book Ratio 3.03
Return on Assets (%) 0.84
Return on Capital (%) 0.85
Particulars MAR 2025 (Values in Cr)
Net Income -6.38
Cash from Operations -9.81
Cash from Investing 3.06
Cash from Financing 0.24
Net change in Cash -6.50
Free Cash Flow -9.76
Particulars MAR 2024 (Values in Cr)
Net Income -1.21
Cash from Operations 4.85
Cash from Investing -1.79
Cash from Financing -1.16
Net change in Cash 1.89
Free Cash Flow 4.91
Particulars MAR 2023 (Values in Cr)
Net Income -4.15
Cash from Operations -1.56
Cash from Investing -4.27
Cash from Financing -2.15
Net change in Cash -7.99
Free Cash Flow -0.78
Particulars MAR 2022 (Values in Cr)
Net Income 12.35
Cash from Operations 8.26
Cash from Investing -0.45
Cash from Financing 1.30
Net change in Cash 9.11
Free Cash Flow 8.46
Particulars MAR 2021 (Values in Cr)
Net Income 2.14
Cash from Operations 1.83
Cash from Investing -0.31
Cash from Financing 3.98
Net change in Cash 5.50
Free Cash Flow 2.14
Particulars MAR 2025 (Values in Cr)
Net Income -0.43
Cash from Operations 0.07
Cash from Investing -0.04
Cash from Financing 0.00
Net change in Cash 0.02
Free Cash Flow 0.13
Particulars MAR 2024 (Values in Cr)
Net Income 0.02
Cash from Operations -0.02
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash -0.02
Free Cash Flow -0.02
Particulars MAR 2023 (Values in Cr)
Net Income -2.63
Cash from Operations -0.07
Cash from Investing 0.08
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow -0.07
Particulars MAR 2022 (Values in Cr)
Net Income 0.35
Cash from Operations 0.54
Cash from Investing -0.38
Cash from Financing -0.13
Net change in Cash 0.02
Free Cash Flow 0.67
Particulars MAR 2021 (Values in Cr)
Net Income 0.10
Cash from Operations 0.27
Cash from Investing -0.18
Cash from Financing -0.09
Net change in Cash -0.01
Free Cash Flow 0.46
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 32.57 13.46 1.57 249.59 23.12 38.85
BLISS GVS PHARMA LTD. 474.55 38.52 4.21 5032.90 118.35 477.30
CIPLA LTD 1350.75 28.67 3.16 109119.71 1165.55 1672.20
FERMENTA BIOTECH LTD. 321.70 14.19 2.32 946.79 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 32.57 22.78 4.19 249.59 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 536.40 24.04 4.18 1550.77 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8520.60 111.28 24.40 21301.50 7630.00 10395.35
BLISS GVS PHARMA LTD. 474.55 51.19 4.35 5032.90 118.35 477.30

DECIPHER LABS LIMITED shareholding pattern

Holding
83.57%
16.42%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

DECIPHER LABS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
6.20 -0.48 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 6.40
  • 26 Days 7.00
  • 10 Days 6.60
  • 50 Days 7.10
  • 12 Days 6.70
  • 100 Days 7.50
  • 20 Days 6.90
  • 200 Days 8.60
6.19 PIVOT
First Support 6.14 First Resistance 6.29 Second Support 6.04 Second Resistance 6.34 Third Support 5.99 Third Resistance 6.44
RSI 34.95 ADX 33.61 MACD -0.28 Williams % R -85.71 Commodity Channel Index (CCI) -153.05
Date 2026-06-17 Week 4428.00 Same Day 5164.00 Month 3652.00
1 Year 1.10 3 Year 0.67
Over 1 Month
-12.62% down
Over 1 Year
-43.72% down
Over 3 Months
10.26% down
Over 3 Years
-30.21% down
Over 6 Months
-35.10% down
Over 5 Years
-31.46% down

DECIPHER LABS LIMITED Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Decipher Labs Ltd?

Answer Field

Decipher Labs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 6.20 as on Jun 19 2026 10:15 AM.

What is the Market Cap of Decipher Labs Ltd Share?

Answer Field

The market cap of Decipher Labs Ltd for NSE ₹ 0.00 & for BSE ₹ 6.30 as on Jun 19 2026 10:15 AM.

What is the 52 Week High and Low of Decipher Labs Ltd?

Answer Field

The 52 Week High and Low of Decipher Labs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 11.95 and ₹ 5.00.

What is 1 year return for Decipher Labs Ltd?

Answer Field

The 1 year returns on the stock has been -43.72%.

What is the P/E Ratio of Decipher Labs Ltd Share?

Answer Field

As on Jun 19 2026 10:15 AM the price-to-earnings (PE) ratio for Decipher Labs Ltd share is -25.96.

What is the PB ratio of Decipher Labs Ltd Share?

Answer Field

As on Jun 19 2026 10:15 AM, the price-to-book (PB) ratio for Decipher Labs Ltd share is 8.15.

How to Buy Decipher Labs Ltd Share?

Answer Field

You can trade in Decipher Labs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Decipher Labs Ltd Share on Bajaj Broking App?

Answer Field

To buy Decipher Labs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Decipher Labs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|